I understand now, yes the name INSTINET was mentioned to me by my broker. It would be interesting to know if others who didn’t settle were also negotiating with that same selling broker.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%